stockrowSyra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024.
- Revenue
- +51.5%
- EPS
- +221.5%
- Free cash flow
- +235.8%
Quarter to September 2026, against a year earlier
Follow SYRA
Alert me
Syra Health Corp. (SYRA) EV/Sales
As of 6 November 2026, Syra Health Corp. (SYRA) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 0.0× (April 2025) to 4.0× (February 2024); the current reading is higher than 72% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | (45.69%) |
| FY2024 | 0.3× | (55.82%) |
| FY2023 | 0.7× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.3× | 32.84% |
| Jun 2026 | 1.0× | 421.88% |
| Mar 2026 | 0.2× | 14.30% |
| Dec 2025 | 0.2× | 46.84% |
| 12 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DCGO DocGo Inc. compare | 0.0× |
| NIVF NewGenIvf Group Limited compare | n/m |
| NVOS Novo Integrated Sciences, Inc. compare | 0.0× |
| PIII P3 Health Partners Inc. compare | 0.1× |
| RHEP Adcare Health Systems Inc compare | 0.5× |
| BTMD biote Corp. compare | 0.8× |
| AMS American Shared Hospital Services compare | 0.9× |
| SYRA Syra Health Corp. | 1.2× |
| CCM Concord Medical Services Holdings Limited compare | 2.6× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)